NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients

Clinical trial NCT06845319 · RECRUITING

Trial details

NCT number: NCT06845319
Sponsor: Medical University of South Carolina
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer

Start date: 2025-10-20
Primary completion: 2027-10-20
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.